42 Biomarkers
| Biomarker | Source | Application | Reference |
|---|---|---|---|
| MiR-125b | fresh specimens of anterior lens capsule | prediction | Yu Qin et al,Biochim Biophys Acta . 2014 |
| miR-126 | serum samples | diagnosis | Federica Barutta,Acta Diabetol,2017 |
| hsa-miR-15a | lens epithelial cells | treatment | OA Abdullah et al.Br J Biomed Sci . 2019 |
| miR-126 | serum samples | diagnosis | Federica Barutta,Acta Diabetol,2017 |
| miR-377-3p | tissue | diagnosis | Li Jiang et al.J Int Med Res . 2021 |
| miR-126, miR-410, and miR-19a | blood | diagnosis | Hanan ElShelmani et al.Transl Vis Sci Technol . 2020 |
| miR-21 | Plasma | diagnosis | Qi Jiang et al. Biosci Rep . 2017 |
| miR-377-3p | Serum | diagnosis | Li Jiang et al. J Int Med Res. 2021 |
| miR-211 | Serum | He-Nan Liu et al. Biochem Biophys Res Commun. 2018 | |
| hsa-miR-210-3p | blood | prediction | Yaoming Liu et al.Invest Ophthalmol Vis Sci . 2019 |
| miR-4667-5p | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-99b-3p | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-637 | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-4490 | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-1253 | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-3190-3p | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-3173-3p | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-608 | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-4725-3p | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-4448 | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR- 323b-5p | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-4538 | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-3913-3p | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-3159 | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-4663 | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-476 | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-4724-5p | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-1306-5p | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-181b-3p | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-433-3p | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-637 | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-1306-5p | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| miR-3159 | blood and AH | diagnosis | Hindle AG,Invest Ophthalmol Vis Sci. 2019 |
| plasma miR-93 | blood | prognosis | Zou, Hui-Ling et al. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie vol. 2017 |
| miR-320a | Blood | prediction | Marcelle SanJuan Ganem Prado et al. BMC Res Notes. 2020 |
| miR-377-3p | Serum | diagnosis | Li Jiang et al. J Int Med Res. 2021 |
| hsa-miR-1260b | blood | diagnosis | Ewa Kosior-Jarecka Graefes Arch Clin Exp Ophthalmol . 2021 |
| hsa-miR-495-3p | blood | diagnosis | Mastropasqua, Rodolfo et al. Diagnostics (Basel, Switzerland) vol. 2021 |
| hsa-miR-23a-3p | blood | diagnosis | Mastropasqua, Rodolfo et al. Diagnostics (Basel, Switzerland) vol. 2021 |
| hsa-miR-15a-5p | blood | diagnosis | Mastropasqua, Rodolfo et al. Diagnostics (Basel, Switzerland) vol. 2021 |
| miRNA-126 | serum samples | diagnosis | Li-Li Qin，Int J Ophthalmol . 2017 |
| hsa-miR-15a | lens epithelial cells | treatment | OA Abdullah et al.Br J Biomed Sci . 2019 |